The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 287,193 ordinary shares in the Company, representing 0.91% of the Company’s current issued share capital.

36.31% of the issued share capital is not in public hands.

The Company is aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:

Number of ordinary shares % of issued share capital
Woodford Investment Management LLP 35.48%
Invesco Ltd 11.91%
Wales Life Sciences Investment Fund LP 9.50%

The above information was last updated on Tuesday, 17 July 2018